Sun Pharmaceuticals Recalls Lisdexamfetamine Capsules Due to Dissolution Test Failure
Sun Pharmaceuticals recalls 60mg lisdexamfetamine capsules (NDC 57664-051-88) due to failed dissolution tests at 9 months. This may affect drug stability and safety.
Lower-risk recall
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25¿C, 60%RH).
Contact the company
What happened, in plain English
Sun Pharmaceuticals is recalling 60mg lisdexamfetamine dimesylate capsules (100-count bottles) because lab tests showed the medication didn't dissolve properly after 9 months. This could mean the drug isn't working as intended or may be unsafe for patients. Read more at govinfonow.com/recall/32025-sun-pharmaceuticals-recalls-lisdexamfetamine-capsules-due-to-dissolution-test-failure.
Source Summary by GovInfoNow · govinfonow.com/recall/32025-sun-pharmaceuticals-recalls-lisdexamfetamine-capsules-due-to-dissolution-test-failure · Updated August 17, 2026 · FDA enforcement record: FDA #D-0516-2025
Cite this page
“Sun Pharmaceuticals Recalls Lisdexamfetamine Capsules Due to Dissolution Test Failure.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32025-sun-pharmaceuticals-recalls-lisdexamfetamine-capsules-due-to-dissolution-test-failure. Based on FDA recall #D-0516-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0516-2025%22&limit=1).
Why it’s dangerous
The capsules failed dissolution tests after 9 months of storage at 25°C and 60% humidity. This means the medication might not release the active ingredient properly when taken, potentially affecting its effectiveness or safety.
Who’s affected
People with prescriptions for lisdexamfetamine dimesylate capsules (60mg, 100-count bottles) from Sun Pharmaceuticals. Those who have the specific lot number AD42648 are most at risk.
How to tell if you have this one
Check for the product name 'Lisdexamfetamine Dimesylate Capsules, 60 mg', 100-count bottles, and lot number AD42648. The expiration date is February 28, 2026.
- Brand
Sun Pharmaceuticals- Category
Drug
What to do — step by step
Check Product Details
Look for the lot number AD42648 on the packaging to confirm if your product is affected.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Recalled units were distributed to 17 distributors who may have further distributed the product nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 37 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Questions people ask
How can I confirm if my product is recalled?
Look for the lot number AD42648 on the packaging. The product was manufactured by OHM Laboratories in New Brunswick, NJ.
Similar recalls
Other Sun Pharmaceuticals recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0516-2025 (June 16, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0516-2025 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.